<p>In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology. The subject was Prostatic Cancer and this publication is based on the presenΒ tations at this meeting by leading authorities in the United Kingdom. The principal objective of these Symposia
Prostate Cancer
β Scribed by Vera Nelen MD (auth.), Jacob Ramon MD, Louis J. Denis MD, FACS (eds.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Year
- 2007
- Tongue
- English
- Leaves
- 273
- Series
- Recent Results in Cancer Research 175
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Prostate cancer treatment dates back almost treatment approaches is examined in the subse- 100years. However, in an era of rapid develop- quent chapters of this volume. ments and innovations in cancer research and Te text addresses the time-honoured h- uro-oncology, there is an increasing need to monal treatment, which has been the mainstay update our knowledge and especially to guide of prostate cancer management for some - our practice by innovations and evidence-based cades. Due to the increased diagnosis of prostate medicine. Prostate cancer is still evolving fol- cancer at earlier stages and the increased use of lowing improvements in disease detection and hormone therapy in earlier disease stages many better understanding of disease characteristics. patients will receive hormone therapy for a long Tis book addresses the current state of the art in period. Tese patients are at risk of acute and this still-developing feld and presents the reader chronic side efects of hormonal therapy. Te- with the information needed to make rational fore, the timing of initiating hormone therapy, patient decisions regarding treatment selection the type of hormone therapy and the monitoring and outcomes. of patients on long-term hormone therapy have Te growing body of knowledge regarding become crucial in the appropriate management epidemiology, pathogenesis, prevention, screen- of patients with prostate cancer. ing, diagnosis and staging is included in the frst Disease management in men with prostate half of the book.
β¦ Table of Contents
Front Matter....Pages i-xiii
Epidemiology of Prostate Cancer....Pages 1-8
Natural History of Prostatic Carcinoma: The Pathologistβs Perspective....Pages 9-24
Prognostic Factors in Prostate Cancer....Pages 25-32
The Prevention of Prostate Cancer....Pages 33-63
Prostate Cancer Screening....Pages 65-81
Diagnosis of Prostate Cancer....Pages 83-99
Does Localized Prostate Cancer Exist?....Pages 101-107
Staging of Prostate Cancer....Pages 109-130
Guidelines and Counselling for Treatment Options in the Management of Prostate Cancer....Pages 131-162
Choices for Surgery....Pages 163-178
Radiation Therapy in Prostate Cancer....Pages 179-199
Cryoablation and High-Intensity Focused Ultrasound....Pages 201-209
The Role of Hormonal Treatment in Prostate Cancer....Pages 211-237
Androgen-Independent Prostate Cancer....Pages 239-249
Prostate Cancer Treatment and Quality of Life....Pages 251-265
Europa Uomo: The European Prostate Cancer Coalition....Pages 267-271
β¦ Subjects
Oncology; Urology/Andrology
π SIMILAR VOLUMES
<p>This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds
This comprehensive and easy-to-read monograph is an authoritative update on clinical prostate cancer. It has been prepared by an international, multidisciplinary team at the invitation of the International Prostate Health Council think tank. The management of prostate cancer a" the most prevalent ty
Around 32,000 men in the UK are diagnosed with prostate cancer each year. It differs from most other cancers in the body, in that small areas of cancer within the prostate are very common and may not grow or cause any problems for many years. It is often it is diagnosed during a routine checkup so m
Prostate cancer (PCa) is a disease with high incidence and prevalence. Early detection of PCa has been an area for research to decrease its morbidity and mortality. The discovery of prostate specific antigen (PSA) revolutionized screening of PCa, which was largely dependent on detection of prostatic
<p><P>More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the worldβs leading experts on prostate cancer detection upd